Lisdexamfetamine Completed Phase 4 Trials for Traumatic Brain Injury (TBI) / Attention Deficit Hyperactivity Disorder (ADHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02712996Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children